Nelson Van Denburg & Campbell Wealth Management Group LLC increased its position in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 6.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,921 shares of the company’s stock after acquiring an additional 1,012 shares during the quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC’s holdings in Express Scripts were worth $1,286,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Omni Partners LLP grew its position in Express Scripts by 22.0% during the 2nd quarter. Omni Partners LLP now owns 281,026 shares of the company’s stock worth $21,698,000 after purchasing an additional 50,664 shares during the last quarter. BlackRock Inc. grew its position in Express Scripts by 1.5% during the 2nd quarter. BlackRock Inc. now owns 35,424,185 shares of the company’s stock worth $2,735,103,000 after purchasing an additional 538,578 shares during the last quarter. Hendershot Investments Inc. grew its position in Express Scripts by 2.7% during the 2nd quarter. Hendershot Investments Inc. now owns 89,125 shares of the company’s stock worth $6,881,000 after purchasing an additional 2,380 shares during the last quarter. Commonwealth Bank of Australia grew its position in Express Scripts by 15.6% during the 2nd quarter. Commonwealth Bank of Australia now owns 296,858 shares of the company’s stock worth $22,915,000 after purchasing an additional 39,983 shares during the last quarter. Finally, Stock Yards Bank & Trust Co. purchased a new stake in Express Scripts during the 2nd quarter worth approximately $1,084,000. Hedge funds and other institutional investors own 84.73% of the company’s stock.
ESRX stock opened at $91.82 on Monday. The firm has a market capitalization of $50.57 billion, a PE ratio of 12.93, a price-to-earnings-growth ratio of 1.13 and a beta of 1.00. The company has a current ratio of 0.71, a quick ratio of 0.59 and a debt-to-equity ratio of 0.69. Express Scripts Holding Co has a 12 month low of $55.80 and a 12 month high of $91.88.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings data on Wednesday, August 1st. The company reported $2.22 EPS for the quarter, beating the consensus estimate of $2.20 by $0.02. The business had revenue of $25.64 billion for the quarter, compared to the consensus estimate of $25.43 billion. Express Scripts had a net margin of 4.65% and a return on equity of 25.49%. The business’s revenue for the quarter was up 1.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.73 EPS. research analysts expect that Express Scripts Holding Co will post 9.07 EPS for the current fiscal year.
In related news, insider Christine Houston sold 12,898 shares of the business’s stock in a transaction on Friday, August 10th. The shares were sold at an average price of $85.00, for a total value of $1,096,330.00. Following the completion of the transaction, the insider now directly owns 110,908 shares in the company, valued at approximately $9,427,180. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.79% of the company’s stock.
Several research firms have weighed in on ESRX. Royal Bank of Canada boosted their target price on shares of Express Scripts to $94.00 and gave the stock an “outperform” rating in a research report on Monday, August 27th. BidaskClub downgraded shares of Express Scripts from a “buy” rating to a “hold” rating in a research report on Tuesday, July 10th. Zacks Investment Research raised shares of Express Scripts from a “strong sell” rating to a “hold” rating in a research report on Tuesday, June 26th. Robert W. Baird downgraded shares of Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 price objective on the stock. in a report on Friday, July 20th. Finally, William Blair raised shares of Express Scripts from a “market perform” rating to an “outperform” rating in a report on Wednesday, August 1st. Three research analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $85.58.
Express Scripts Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Further Reading: Google Finance Portfolio
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.